CCNE1 and PLK1 Mediate Resistance to Palbociclib in HR+/HER2- Metastatic Breast Cancer.

Clin Cancer Res · 2023 · PMC10102847 · PMID 36749874

Europe PMC DOI

hedged sentence

0.0631

closest p · 1.3× alpha

0.0631

boldest claim

The sentences

a numerical trendP value = 0.0631so close (0.05 < p ≤ 0.1)

LumB tumors showed a numerical trend to better PFS with low CCNE1 (median PFS 12.02 vs. 7.06 months, HR = 1.57; 95% CI, 0.97–2.56; P value = 0.0631).

also in 227 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.